Health Innovation and Entrepreneurship

Charles Antoine Janssen shares his views on how investments aimed at improving the health of the most vulnerable populations in the world can still generate adequate financial returns for the investors. Charles Antoine Janssen is vice chair of UCB, a global biopharmaceutical company headquartered in Belgium. And he's also managing partner of Kois https://koisinvest.com and Healthquad. Charles Antoine has experience in fundraising for social impact funds as well as investing the money raised in companies that want to solve societal problems. He shares his views on how investments aimed at improving the health of the most vulnerable populations in the world can still generate adequate financial returns for the investors. https://www.ucb.com https://healthquad.in

Rita Hendricusdottir talks to Bruno about Oxford spin-out, Regmetrics, which supports entrepreneurs bridge the knowledge gap between science and law. Rita is the CEO and co-founder of Regmetrics, a spin-out from the University of Oxford. Rita and her co-founder Jeroen Bergman were developing a medical device and discovered like many other innovators that the regulations are a real struggle and often determine whether the technology reaches the market or not. So she set out to bridge the knowledge gap between science and law. Regmetrics supports entrepreneurs in defining the intended purpose of their innovation and the regulatory requirements and standards that they must meet. https://www.reg-metrics.com

Integrating Artificial Intelligence in medical imaging for increased accuracy, accessibility, and affordability. Prashant Warier is co-founder and CEO at Qure.ai. Prashant holds a MS and PhD in Operations Research from the Georgia Institute of Technology, where he excelled in applied mathematics and computation. With a career spanning over two decades, Prashant has successfully developed and commercialized various data science applications across multiple industries such as trucking, fashion and now healthcare. Qure.ai, founded in 2016, is disrupting traditional radiology practices by enhancing imaging accuracy with artificial intelligence and machine learning tools. More than ten products in Qure.ai’s portfolio have MDR and FDA clearances and these products are being adopted in the screening and diagnosis of diseases such as Lung Cancer, Tuberculosis and Cerebral Stroke in over 90 countries in North America, Europe, Asia, and Africa. Its mission is to make diagnostic imaging, such as X-rays and CTs, not only more precise but also widely accessible and affordable. MSc in International Health and Tropical Medicine (IHTM) - https://www.tropicalmedicine.ox.ac.uk/study-with-us/msc-ihtm

Offering a 10$ DNA based diagnostic test for blood disorders and cancer. Anna Shuh is a medical doctor, an academic researcher, and a healthcare entrepreneur. She started working at Oxford University in 2006 as the clinical director of the haematology lab at Oxford University Hospitals. In 2014, she was appointed as Professor of Molecular Diagnostics. More recently, Anna joined the Muhimbili University for Health and Allied Sciences faculty in Tanzania and co-founded a social enterprise, Seren. Seren is a social enterprise spin out of Oxford University and aims to promote and support diagnostics in low- and middle-income countries with an initial focus on DNA based tests for blood disorders and cancers. Historically, DNA sequencing required expert staff and high-tech equipment; interpreting tests is slow and expensive, and blood data often needs to be sent overseas to be analysed. The first facility in Dar-es-Salaam has now opened and will offer DNA tests for as little as $10 using low cost and low maintenance equipment, while cloud-based data systems allow remote analysis by experts so that samples do not need to be sent abroad. To prepare for the transfer of all testing to SEREN, Oxford has provided training for laboratory technicians and health professionals from five hospitals in Tanzania and Uganda. MSc in International Health and Tropical Medicine (IHTM) - https://www.tropicalmedicine.ox.ac.uk/study-with-us/msc-ihtm

Implementing a digital platform for essential health packages and universal health coverage. Bahbak is the co-founder and CEO of Elephant. He holds a Bachelor of Science from the University of St Andrews and he graduated with a degree in medicine from the University of Manchester in 2004. He subsequently trained and worked as a psychiatrist in the National Health Service. From 2009 to 2016, he was co-founder and director of a business providing health, social care, and housing solutions for people with dementia. After a brief return to the NHS as a psychiatrist he launched Elephant Healthcare in the Summer of 2018. Elephant Healthcare is a global health technology business, headquartered in the UK with operations in Africa and Asia. The first countries adopting Elephant Health’s solutions are Nigeria, Kenya, and Pakistan. In these countries, most of the electronic health records are still paper based and the health facilities and health authorities don’t have timely, complete, and reliable information for important functions such as disease monitoring, resource distribution, quality assessment and performance improvement. Elephant Health has developed several modules that can assist health facilities such as primary health care centres or hospitals with patient scheduling, inventory management, invoicing, and referral management. Elephants’ customers are governments and public health authorities which is a very different approach than what most start-up take. MSc in International Health and Tropical Medicine (IHTM) - https://www.tropicalmedicine.ox.ac.uk/study-with-us/msc-ihtm